Supreme Court Asked to Restore Access to Abortion Pill by Mail
The New York Times • • nation
Key Points:
- A manufacturer of the abortion pill mifepristone has asked the Supreme Court to immediately restore full access to the medication after a federal appeals court temporarily restricted telemedicine prescriptions and mail delivery nationwide.
- The Fifth Circuit Court sided with Louisiana officials who sued the FDA, reinstating an in-person requirement for prescribing mifepristone that had been lifted in 2021, citing the state's near-total abortion ban.
- The lower court's order could disrupt one of the main methods for obtaining abortions, as about 25% of U.S. abortions are currently provided through telemedicine.
- Danco Laboratories and GenBioPro, manufacturers of mifepristone and defendants in the Louisiana lawsuit, have filed emergency requests with the Supreme Court to overturn the appeals court's ruling.
